Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Communiqué Awards 2015 now open for entries

Health communications programme sees a number of category changes this year

Gilead makes senior changes

Expanded roles for Andrew Cheng and Taiyin Yang

- PMLiVE

Sanofi launches inhaled insulin in US

Partners with MannKind on only diabetes treatment of its kind

- PMLiVE

The problem with pills

Conventional solid dosage forms have failed to keep pace with modern consumers’ evolving demands

Roche - Basel

Roche’s PD-1 wins second FDA ‘breakthrough’ status

Will accelerate review of MPDL3280A in lung cancer

- PMLiVE

US seeking price cuts for Medicare drugs

White House proposes allowing Medicare Part D to haggle with pharma companies for discounts

- PMLiVE

Lilly and Boehringer claim first place for diabetes combination

US FDA backs Glyxambi as first combination of SGLT2 inhibitor and DPP-4 inhibitor.

Gathering pace: adaptive pathways

EMA looks at how the model could work in practice and picks first drugs for its pilot project

Searching for junk

The pharma industry might be focusing on the wrong acquisitions

- PMLiVE

Extension for head of Germany’s VFA

Birgit Fischer to remain as chief executive of pharma trade body until 2019          

- PMLiVE

VCCP Health and Havas Life Medicom tie for first at PM Society Awards

Eachagency picked up three Gold trophies at annual ceremony in London

UK flag

No further price cut for non-PPRS drugs in UK

But industry concerned over long-term plan for statutory medicines on the NHS

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links